Skip to main content
. 2020 Oct 29;12:137. doi: 10.1186/s13195-020-00703-5

Fig. 1.

Fig. 1

Considerations and an example for optimizing LBD clinical trial design. CSF, cerebrospinal fluid; DLB, dementia with Lewy bodies; LBD, Lewy body dementia; MCI, mild cognitive impairment; PDD, Parkinson’s disease dementia